Better the 2nd time around: Auxilium accepts Endo's $2.6B buyout offer

After rebuffing an unsolicited takeover attempt last month, Auxilium Pharmaceuticals Inc. decided to accept a revised buyout offer from Endo International in a deal involving two biopharmaceutical companies with strong ties to this region...